AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
31min chapter
Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman
Blood Cancer Talks
DARA Maintenance and Deepening MRD Negativity
This chapter discusses the use of Dara (CD38 monoclonal antibody) during maintenance therapy for patients with multiple myeloma. It analyzes the results of a trial comparing the deepening of MRD negativity after consolidation in patients receiving Dara VRD and Lenalidomide versus those receiving VRD. The chapter also explores ongoing trials investigating the impact of CD38 as maintenance therapy and presents real-world data comparing Dara-VRD with VRD.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode